Which specialists should be consulted for a patient with possible central nervous system complications of varicella‑zoster infection, new headache, and a shingles rash (especially if involving the ophthalmic division) to evaluate for CNS involvement, giant cell arteritis, and need for antiviral therapy?

Specialist Referral for VZV with CNS Complications

Immediately refer to ophthalmology for any patient with herpes zoster involving the ophthalmic division (herpes zoster ophthalmicus), and consult neurology for suspected CNS involvement; additionally, consider rheumatology consultation if giant cell arteritis is suspected based on age >50 years, elevated inflammatory markers, and temporal artery symptoms.

Ophthalmology Referral (Urgent/Emergent)

Ophthalmology consultation is typically indicated for herpes zoster ophthalmicus 1. This is critical because:

• Ophthalmic division involvement can result in wide-ranging ocular morbidity
• Early specialist evaluation is essential even with systemic antiviral therapy initiated
• Vision loss is a recognized complication requiring specialized assessment and management

Neurology Consultation

For suspected CNS complications (new headache with shingles), neurology should evaluate for:

• VZV vasculopathy - can cause stroke, both ischemic and hemorrhagic 2, 3
• VZV encephalitis - presents with altered mental status, seizures, focal neurologic deficits 4
• VZV meningitis or myelitis 5, 3

Key Clinical Features Warranting Neurologic Evaluation:

• Altered consciousness or behavioral changes
• Seizures or focal neurologic deficits
• Severe or progressive headache beyond typical zoster pain
• Any signs of stroke (weakness, speech changes, visual field defects)

Neurologists will coordinate appropriate diagnostic workup including CSF analysis with VZV PCR (sensitivity 80-95%, specificity 95%) 4 and MRI imaging, which may reveal temporal lobe involvement or vascular changes 4, 3.

Rheumatology Consultation

Consider rheumatology referral when clinical features suggest giant cell arteritis, particularly:

• Age >50 years
• New-onset headache with temporal artery abnormalities (nodularity, decreased pulsations, tenderness)
• Jaw claudication
• Elevated ESR/CRP
• Visual disturbances
• Constitutional symptoms (fever, night sweats, malaise)
• History of polymyalgia rheumatica

Critical Evidence Linking VZV and GCA:

Recent research demonstrates that VZV is present in temporal arteries of both biopsy-positive and biopsy-negative GCA patients 6, 7. Specifically:

• VZV was found in 21% of clinically suspected but biopsy-negative GCA cases 7
• All patients with VZV-positive temporal arteries presented with full clinical and laboratory features of GCA 7
• Multifocal VZV vasculopathy can mimic GCA completely 7, 2

This overlap creates diagnostic complexity requiring rheumatologic expertise, especially since:

• Temporal artery biopsy may be pathologically negative despite clinical GCA 6
• VZV may trigger the immunopathology of GCA 6, 8
• Treatment implications differ (corticosteroids for GCA vs. high-dose IV acyclovir for VZV vasculopathy) 5

Treatment Considerations While Arranging Consultations

Initiate high-dose IV acyclovir (10 mg/kg every 8 hours) immediately for suspected VZV CNS involvement 4, 5. For VZV vasculopathy specifically, treatment should be:

• IV acyclovir for 7 days minimum 5
• Consider adjunctive corticosteroids (prednisone 60-80 mg/day for 3-5 days) to reduce vascular inflammation 5

Common Pitfalls to Avoid

• Don't wait for rash confirmation - VZV CNS complications can occur without characteristic skin eruptions 4, 5, 3
• Don't dismiss normal initial MRI - imaging may be initially normal or remain normal during illness course 4
• Don't rely solely on temporal artery biopsy - skip lesions are common and biopsies can be falsely negative despite true disease 6, 7
• Don't assume immunocompetence protects - while immunocompromised patients are at higher risk, severe VZV CNS complications occur in immunocompetent individuals 2, 5